Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2019-03-05 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-03-05 English
FORM 4
Director's Dealing
2019-03-05 English
FORM 10-K
Annual Report FY 2018
2019-02-26 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 26, 2019, reporting the company's results of operations for the three months and year ended December 31, 2018. It references a press release attached as Exhibit 99.1 containing the financial results. The document itself does not contain detailed financial statements or substantive financial data but rather announces the results and includes a press release. The length is 3348 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document is classified as an Earnings Release (ER) since it is the initial announcement of quarterly/periodical financial results with key highlights only, and not a full Annual Report or Interim Report. Therefore, the appropriate classification is ER with high confidence.
2019-02-26 English
Regulatory Filings 2019
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, fiscal period dates, or document titles that would allow identification of a specific filing type. There is no indication of the document being a report itself or an announcement. Given the lack of discernible information and the fallback rule, the document should be classified as a Regulatory Filing (RNS). The confidence is moderate due to the inability to extract meaningful content.
2019-02-19 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.